title: Midostaurin in Advanced Systemic Mastocytosis.
authors.affiliation: French National Reference Center for Mastocytosis (CEREMAST), Paris, France.
authors.forename: Marie-Olivia
authors.initials: MO
authors.lastname: Chandesris
authors.affiliation: University of Lower Normandy School of Medicine, Caen, France.
authors.forename: Gandhi
authors.initials: G
authors.lastname: Damaj
authors.affiliation: Necker University Hospital, Paris, France.
authors.forename: Danielle
authors.initials: D
authors.lastname: Canioni
authors.affiliation: Necker University Hospital, Paris, France.
authors.forename: Chantal
authors.initials: C
authors.lastname: Brouzes
authors.affiliation: Necker University Hospital, Paris, France.
authors.forename: Ludovic
authors.initials: L
authors.lastname: Lhermitte
authors.affiliation: Paoli Calmettes Institute, Marseille, France.
authors.forename: Katia
authors.initials: K
authors.lastname: Hanssens
authors.affiliation: Necker University Hospital, Paris, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Frenzel
authors.affiliation: Necker University Hospital, Paris, France.
authors.forename: Zoubair
authors.initials: Z
authors.lastname: Cherquaoui
authors.affiliation: Lyon Sud University Hospital, Lyon, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Durieu
authors.affiliation: Lyon Sud University Hospital, Lyon, France.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Durupt
authors.affiliation: Tours University Hospital, Tours, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Gyan
authors.affiliation: Purpan University Hospital, Toulouse, France.
authors.forename: Odille
authors.initials: O
authors.lastname: Beyne-Rauzy
authors.affiliation: Lille University Hospital, Lille, France.
authors.forename: David
authors.initials: D
authors.lastname: Launay
authors.affiliation: Vesoul Regional University Hospital, Vesoul, France.
authors.forename: Cyril
authors.initials: C
authors.lastname: Faure
authors.affiliation: Hôtel-Dieu University Hospital, Nantes, France.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Hamidou
authors.affiliation: Rennes University Hospital, Rennes, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Besnard
authors.affiliation: Amiens University Hospital, Amiens, France.
authors.forename: Momar
authors.initials: M
authors.lastname: Diouf
authors.affiliation: Saint-Eloi University Hospital, Montpellier, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Schiffmann
authors.affiliation: Bretagne Sud Regional Hospital, Lorient, France.
authors.forename: Mathilde
authors.initials: M
authors.lastname: Niault
authors.affiliation: Archet-1 University Hospital, Nice, France.
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Jeandel
authors.affiliation: Nancy University Hospital, Nancy, France.
authors.forename: Dana
authors.initials: D
authors.lastname: Ranta
authors.affiliation: Grenoble University Hospital, Grenoble, France.
authors.forename: Remi
authors.initials: R
authors.lastname: Gressin
authors.affiliation: University of Lower Normandy School of Medicine, Caen, France.
authors.forename: Sylvain
authors.initials: S
authors.lastname: Chantepie
authors.affiliation: Tenon University Hospital, Paris, France.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Barete
authors.affiliation: Paoli Calmettes Institute, Marseille, France.
authors.forename: Patrice
authors.initials: P
authors.lastname: Dubreuil
authors.affiliation: Necker University Hospital, Paris, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Bourget
authors.affiliation: Necker University Hospital, Paris, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
authors.affiliation: Imagine Institute, Paris, France ohermine@gmail.com.
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
mesh_terms: D017668:Age of Onset; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D034721:Mastocytosis, Systemic / Q000188:drug therapy*; D015999:Multivariate Analysis; D019311:Staurosporine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D019311:Staurosporine; C059539:midostaurin